From DMT: The Spirit Molecule
09:03 min
CLEAR ALL
After decades in the shadows, new studies are looking at psychedelic drugs and their efficacy at treating a variety of psychological issues, including depression.
A renaissance is underway in the scientific study of psychedelics, both as a mode of therapy for mental illness and as a tool for understanding the mind.
How could LSD and psilocybin help with mental health, palliative care and addictive behaviours? What was the point of a psilocybin mushroom evolving the way that it did? Michael Pollan explores the “second wave” of international research and discusses what psychedelic drugs may teach us about...
As one of our most brilliant and clear-eyed explorers of such topics as plant intelligence and how we feed ourselves, Michael will share his luminous insights from what began as investigative reportage and became a very personal interior journey into the mystery of consciousness and the nature of...
1
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.
Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.
This presentation summarizes past and ongoing studies from the Johns Hopkins Psilocybin Research Project, which started about 15 years ago.
Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.